Afya is an education & training services business based in the US. Afya shares (AFYA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $18.95 – a decrease of 0.68% over the previous week.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $18.95 |
|---|---|
| 52-week range | $14.33 - $19.80 |
| 50-day moving average | $17.67 |
| 200-day moving average | $16.94 |
| Wall St. target price | $19.56 |
| PE ratio | 15.6721 |
| Dividend yield | $1.349 (1.21%) |
| Earnings per share (TTM) | $1.22 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $19.12 from 2025-05-02
| 1 week (2025-04-25) | 2.91% |
|---|---|
| 1 month (2025-04-04) | 11.94% |
| 3 months (2025-02-06) | 14.63% |
| 6 months (2024-11-06) | 6.88% |
| 1 year (2024-05-06) | 6.99% |
|---|---|
| 2 years (2023-05-03) | 74.18% |
| 3 years (2022-05-02) | 28.52% |
| 5 years (2020-05-05) | 20.4046 |
Valuing Afya stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Afya's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Afya's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Afya shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Afya's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 billion.
The EBITDA is a measure of a Afya's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.3 billion |
|---|---|
| Operating margin TTM | 30.31% |
| Gross profit TTM | $2.1 billion |
| Return on assets TTM | 7.72% |
| Return on equity TTM | 16.32% |
| Profit margin | 19.11% |
| Book value | $47.30 |
| Market Capitalization | $1.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 3.75% of net profits
Recently Afya has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Afya shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Afya's case, that would currently equate to about $1.349 per share.
While Afya's payout ratio might seem low, this can signify that Afya is investing more in its future growth.
Afya's most recent dividend payout was on 3 April 2025. The latest dividend was paid out to all shareholders who bought their shares by 25 March 2025 (the "ex-dividend date").
Over the last 12 months, Afya's shares have ranged in value from as little as $14.3336 up to $19.8024. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Afya's is 0.673. This would suggest that Afya's shares are less volatile than average (for this exchange).
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers printed and digital content and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Compare pros, cons, research tools and reviews for these two trading platforms.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.